Which criteria should we use to evaluate the efficacy of immune-checkpoint inhibitors?
Ann Transl Med
.
2018 Jun;6(11):222.
doi: 10.21037/atm.2018.04.17.
Authors
Yuki Kataoka
1
2
,
Katsuya Hirano
2
Affiliations
1
Hospital Care Research Unit Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
2
Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
PMID:
30023385
PMCID:
PMC6035987
DOI:
10.21037/atm.2018.04.17
No abstract available
Publication types
Editorial
Comment